TheraMicro, LLC
Developer and supplier of minimally invasive biologic allograft materials and related clinical support for extremity surgical care. Product portfolio focuses on extracellular-matrix-based scaffolds (dermal, placental, periosteal, cortical fiber and viscoelastic matrices) processed for sterility, hydration control, and handling for use in wound care, soft-tissue repair and orthopedic procedures. The company reports in vitro and in vivo testing data, provides clinical education and reimbursement support, and maintains compliance programs aligned with medical device industry ethical guidelines.
Industries
N/A
Products
AlloStat D
Deep dermal matrix allograft preserving deep dermal bioactive elements and dense collagen/elastin fibers; available meshed and non-meshed with reversible orientation and terminal sterilization.
AlloStat GFx
Composite allograft integrating demineralized long cortical fibers with periosteal collagen matrix engineered to preserve and present endogenous osteogenic and angiogenic growth factors.
MicroVisc
Injectable allograft intended to supplement soft tissue padding in the foot to reduce pressure at bony prominences; delivered via sterile image-guided cannula.
CentaVisc
Viscoelastic extracellular matrix graft composed of interconnected collagen fibers, glycosaminoglycans and proteoglycans designed to conform to surgical defect sites and retain biological fluids.
Procenta
Placental connective tissue–derived extracellular matrix provided as a conformable wound cover; terminally sterilized and listed with HCPCS code Q4310 for wound cover applications.
Stemnios
Multi-layer placental matrix comprising chorion and amnion layers designed to deliver growth-factor-rich coverage to wounds and support epithelial regeneration.
AlloStat D
Deep dermal matrix allograft preserving deep dermal bioactive elements and dense collagen/elastin fibers; available meshed and non-meshed with reversible orientation and terminal sterilization.
AlloStat GFx
Composite allograft integrating demineralized long cortical fibers with periosteal collagen matrix engineered to preserve and present endogenous osteogenic and angiogenic growth factors.
MicroVisc
Injectable allograft intended to supplement soft tissue padding in the foot to reduce pressure at bony prominences; delivered via sterile image-guided cannula.
CentaVisc
Viscoelastic extracellular matrix graft composed of interconnected collagen fibers, glycosaminoglycans and proteoglycans designed to conform to surgical defect sites and retain biological fluids.
Procenta
Placental connective tissue–derived extracellular matrix provided as a conformable wound cover; terminally sterilized and listed with HCPCS code Q4310 for wound cover applications.
Stemnios
Multi-layer placental matrix comprising chorion and amnion layers designed to deliver growth-factor-rich coverage to wounds and support epithelial regeneration.
Services
Clinical education and training
Training programs and materials for healthcare professionals on safe and effective use of allograft products.
Reimbursement and coding support
Guidance on HCPCS coding and payer considerations for product billing and coverage.
Commercial distribution and customer service
Order processing, distributor inquiries and customer support for product distribution and ordering.
Clinical education and training
Training programs and materials for healthcare professionals on safe and effective use of allograft products.
Reimbursement and coding support
Guidance on HCPCS coding and payer considerations for product billing and coverage.
Commercial distribution and customer service
Order processing, distributor inquiries and customer support for product distribution and ordering.
Expertise Areas
- Biologic allograft development
- Extracellular matrix scaffold design
- Wound care and soft-tissue repair
- Extremity orthopedic surgical treatments
Key Technologies
- Lyophilization
- Aseptic processing
- Terminal sterilization (SAL 10^-6)
- Extracellular matrix (ECM) scaffolds